Kura Oncology, Inc. (FRA:KUR)

Kura Oncology Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	911	654	966	793	819	1,763
Market Cap Growth	-33.06%	-32.29%	21.90%	-3.25%	-53.53%	217.55%
Enterprise Value	454	231	573	397	348	1,510
Last Close Price	10.34	8.20	12.80	11.40	12.80	27.40
PS Ratio	10.28	12.57	-	-	-	-
PB Ratio	4.41	1.64	2.69	2.02	1.84	3.53
P/TBV Ratio	4.41	1.64	2.69	2.02	1.84	3.53
P/FCF Ratio	12.86	5.06	-	-	-	-
P/OCF Ratio	12.17	5.04	-	-	-	-
EV/Sales Ratio	5.06	4.43	-	-	-	-
EV/FCF Ratio	6.41	1.78	-	-	-	-
Debt / Equity Ratio	0.08	0.04	0.04	0.03	0.01	0.03
Debt / FCF Ratio	0.23	0.12	-	-	-	-
Asset Turnover	0.18	0.09	-	-	-	-
Quick Ratio	4.83	9.32	12.05	18.24	23.13	24.34
Current Ratio	5.12	9.46	12.26	18.56	23.26	24.49
Return on Equity (ROE)	-65.10%	-42.91%	-37.34%	-29.31%	-23.35%	-21.60%
Return on Assets (ROA)	-26.57%	-19.97%	-22.89%	-17.65%	-13.89%	-12.92%
Return on Capital (ROIC)	-42.68%	-28.59%	-24.42%	-18.45%	-14.40%	-13.48%
Return on Capital Employed (ROCE)	-45.40%	-28.40%	-40.10%	-32.40%	-25.70%	-14.80%
Earnings Yield	-20.29%	-25.69%	-14.29%	-16.04%	-14.00%	-4.16%
FCF Yield	7.78%	19.76%	-11.70%	-13.07%	-11.34%	-3.34%
Buyback Yield / Dilution	-4.45%	-17.66%	-9.31%	-0.96%	-25.01%	-26.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.